ea0015p339 | Thyroid | SFEBES2008
Mettayil Jeevan
, Matthews Lucy
, Neoh C
, Dickinson A
, Perros Petros
, Pearce Simon
Thyroid eye disease is the most frequent extrathyroidal manifestation of GravesÂ’ disease. Severe and active disease is frequently treated with immunosuppressive therapy. IV methylprednisolone (500 mg daily for 3 days) is the treatment of choice with efficacy rates of up to 77%. New onset glucose intolerance/diabetes is the most relevant side effect of this treatment. We investigated the risk of steroid induced diabetes and the risk factors for its development.<p class...